Galán L, Talavera K, Vassort G, Alvarez J L
Laboratorio de Electrofisiología Instituto de Cardiología y Cirugía Cardiovascular, La Habana, Cuba.
Eur J Pharmacol. 1998 Sep 11;357(1):93-105. doi: 10.1016/s0014-2999(98)00543-3.
The two novel dihydropyridines, oxodipine and elgodipine greatly depressed the KCl-induced contraction of rabbit aorta and decreased the cardiac force of contraction of rat ventricular strips with lower potency. Both compounds markedly shortened cardiac action potentials. In rat cultured neonatal ventricular myocytes, oxodipine and elgodipine decreased the L-type Ca2+ current (I(CaL)) with IC50 of 0.24 and 0.33 microM respectively while oxodipine was slightly more potent on the T-type Ca2+ current (I(CaT)) than elgodipine (IC50 = 0.41 vs. 2.18 microM). Both compounds were less potent in inhibiting I(CaL) of adult cardiomyocytes. Oxodipine exhibited mostly a tonic block of both currents while elgodipine induced mainly a use-dependent block. Oxodipine and elgodipine increased by at least one order of magnitude their inhibitory potency on I(CaT) and I(CaL) when the cells were partially depolarized. We conclude that the mechanisms of inhibition of Ca2+ channels by these two dihydropyridines are different and suggest that the underlying mechanism of vascular selectivity is the voltage-dependent block of I(CaL), with the use-dependent inhibition of Ca2+ currents by elgodipine further contributing to this selectivity.
两种新型二氢吡啶类药物,奥索地平(oxodipine)和依尔戈地平(elgodipine)能显著抑制氯化钾诱导的兔主动脉收缩,并以较低的效能降低大鼠心室肌条的收缩力。这两种化合物均能显著缩短心脏动作电位。在大鼠原代培养新生心室肌细胞中,奥索地平(oxodipine)和依尔戈地平(elgodipine)分别以0.24和0.33微摩尔的半数抑制浓度(IC50)降低L型钙电流(I(CaL)),而奥索地平(oxodipine)对T型钙电流(I(CaT))的抑制作用略强于依尔戈地平(elgodipine)(IC50分别为0.41和2.18微摩尔)。这两种化合物对成年心肌细胞I(CaL)的抑制作用较弱。奥索地平(oxodipine)对两种电流大多表现为持续性阻滞,而依尔戈地平(elgodipine)主要诱导使用依赖性阻滞。当细胞部分去极化时,奥索地平(oxodipine)和依尔戈地平(elgodipine)对I(CaT)和I(CaL)的抑制效能至少增加一个数量级。我们得出结论,这两种二氢吡啶类药物对钙通道的抑制机制不同,并表明血管选择性的潜在机制是I(CaL)的电压依赖性阻滞,依尔戈地平(elgodipine)对钙电流的使用依赖性抑制进一步促成了这种选择性。